Clinical Trial: Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects

U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07134478) titled 'Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects' on Aug. 14.

Brief Summary: This is a single-center, open-label, two-period, fixed-sequence clinical study to evaluate the effect of Rifampicin on the pharmacokinetics of HSK31858 in healthy subjects

Study Start Date: Oct. 28, 2024

Study Type: INTERVENTIONAL

Condition: Healthy Subjects

Intervention: DRUG: HSK31858 Tablets On the morning of Day 1, a single dose of HSK31858 tablets 40 mg will be administered. Rifampicin capsules After a 5-day washout period, a single dose of rifampicin capsules 600 mg wi

HSK31858 Tablets ...